Associated with Interventional Fluoroscopy
2025 Updated Analysis
Minimally invasive treatment of many cardio-, neuro-, and peripheral vascular conditions has surpassed open surgeries driven by numerous benefits, including fewer major adverse events, shorter hospital stays, and faster recovery. These endovascular procedures would not have been possible without fluoroscopy, which provides real-time images of the location and movement of therapeutic catheters inside the body. However, over the past two decades, there has been increasing scientific and clinical evidence that chronic exposure to fluoroscopy, which emits low-dose ionizing radiation, is putting interventional medical professionals at risk for serious health conditions, including cancer.
In December 2018, ORSIF published the first economic analysis of the impact of these health-related occupational hazards, estimating annual costs of at least $49 million in the United States. This interactive web application updates that analysis using current federal economic valuations, workforce data, and clinical research. Based on updated parameters, the 2025 estimate has risen to approximately $88.7 million per year—an 81% increase from the 2018 baseline.
This estimate excludes the treatment of non-acute medical conditions, such as precursors to cataracts, cognitive decline, and risks to reproductive health. It also does not account for turnover costs of experienced physicians nor potential litigation from physicians or patients. Absent investment in radiation exposure control technologies, economic costs will likely continue to increase based on the continued shift to minimally invasive procedures.
Physicians and support staff exposed to occupational radiation in interventional fluoroscopy
Based on data from medical colleges and boards, there are approximately 11,626 interventional physicians in the US. In addition, there are approximately 13,000 nurses and 11,300 technicians involved in fluoroscopy-guided interventional procedures. The Bureau of Labor Statistics reports 64,700 "Cardiovascular Technologists and Technicians," but this broader category includes echo technicians, stress test technicians, and others not routinely exposed to fluoroscopy.
Scientific evidence documenting the health risks that interventional healthcare professionals face
Exposure to even low-dose radiation increases the risk of developing cancer. The Biological Effects of Ionizing Radiation (BEIR) Committee found that there is a linear dose-response relationship between exposure to radiation and the development of cancer.1 At 100 mSv cumulative exposure—the estimated lifetime mean for interventional physicians—the risk of cancer is 1%.2
Although 1% may seem low, OSHA considers 0.1% excess risk to be "significant." The incremental risk of 1% for cancer (1 in 100) is comparable to the risk of dying in a motor vehicle accident (1 in 112) or unintentional poisoning (1 in 109).3
Malignant brain tumors among interventional healthcare providers were first reported in 1997. Since that time, 43 cases have been documented among interventional cardiologists, with a mean latency of 23.5 years from first exposure.4 Notably, 85% of these tumors were located on the left side of the brain—the side closest to the radiation source during fluoroscopy—strongly suggesting occupational etiology rather than random occurrence.
Beyond brain tumors, a Mayo Clinic study found notably higher rates of breast cancer and leukemia among interventional HCPs compared to non-interventional colleagues.5 The WIN for Safety survey reported that 4.4% of female interventional cardiology workers had been diagnosed with cancer, compared to 1.8% of male workers—a finding that warrants further investigation given the growing female representation in interventional specialties.
Interventional medical professionals wear leaded aprons and other personal protective equipment (PPE) to shield their bodies from scatter radiation. The weight of leaded PPE exerts continuous pressure on the spine, neck, hips, and knees. In addition, interventionalists often have to place their bodies in awkward positions to view monitors or maintain positioning behind radio-protective shields, which intensifies the strain that PPE places on the musculoskeletal system.6
In the 2023 SCAI survey, 66% of interventional cardiologists reported musculoskeletal problems—up from 53% in 2018.7 The anatomical distribution is striking: interventional cardiologists experience cervical disc disease at 10 times the rate of the general population and lumbar injuries at 3 times the general population rate. A 2025 German study found that 82% of interventionalists reported lumbar complaints and 78% reported cervical complaints.
Of respondents who had been in practice for at least five years, 85% had at least one musculoskeletal problem. Interventionalists with more than 20 years of experience reported the highest rates of back pain, with spinal disease in nearly 60%. The high incidence has led to concern that physicians in cath labs may face shortened careers, leading to a depletion of trained interventionalists.8
Clinical studies document measurable eye lens changes in interventional cardiologists. The IC-CATARACT study found that 14% of interventionalists had frank lens opacities compared to 6% of age-matched controls.9 The O'CLOC study in France found posterior subcapsular lens opacities in 17% of interventional cardiologists versus 5% of unexposed controls. Overall, roughly 50% of cath lab physicians develop detectable PSC opacities—up to 5 times more frequently than unexposed individuals of the same age and sex.
The International Commission on Radiological Protection (ICRP) recognized this risk by lowering the recommended annual eye lens exposure limit from 150 mSv to 20 mSv in 2012—a sevenfold reduction. However, the average time for a recorded PSC opacity to progress to a visually significant cataract requiring surgery is unknown. As a result, this model does not assume an economic cost for this highly prevalent occupational hazard.
Studies within the Healthy Cath Lab project have documented measurable biological markers of premature aging in interventional cardiologists.10 Neuropsychological testing of interventionalists (average age 46 for men, 43 for women) found significantly lower scores on verbal long-term memory, fluency, and short-term visual memory compared to age-matched controls—cognitive functions typically seen declining in much older individuals. The investigators characterized this as premature brain aging, calling it a "neglected and underestimated" effect of chronic radiation exposure.
A companion study found that interventionalists had increased carotid intima-media thickness (CIMT)—a marker of subclinical atherosclerosis—and shorter leukocyte telomere length compared to unexposed controls of the same age. Telomere shortening is a well-established biomarker of biological aging and a predictor of cardiovascular disease. These findings suggest that chronic low-dose radiation exposure may accelerate both cognitive and vascular aging, with implications that extend beyond cancer risk.
Key parameters driving the increase in estimated economic costs
The federal government's standard valuation for mortality risk, used by regulatory agencies to assess life-saving measures.
Workers' compensation costs for spinal injuries have more than doubled since 2018.
Average MSD cost for nurses and technicians based on updated workers' compensation data.
The proportion of interventional cardiologists reporting musculoskeletal problems has increased despite awareness.
Based on incidence and valuation assumptions, the economic cost of adverse health effects of occupational exposure to interventional fluoroscopy is estimated to be at least $88.7 million annually in the US.
| Category | Group | 2018 Cost | 2025 Cost | Change |
|---|
The economic model does not attempt to quantify several consequences that could arise from adverse health effects of chronic exposure to ionizing radiation
In the case of nonfatal cancer or major MSD, an interventional physician could face substantial work absences, impacting hospital revenues and the total number of procedures performed annually.
Some interventional physicians may opt to retire early because of adverse occupational hazards. Replacement costs have been estimated at $1.8-2.8 million per specialty physician. Additionally, interventional cardiologists generate approximately $3.48 million in annual procedure revenue—meaning each premature retirement represents substantial economic loss beyond direct health costs.
While 50% of interventionalists develop lens opacities, the progression rate to visually significant cataracts requiring surgery is unknown. No longitudinal studies have tracked this population.
If hospitals don't invest in available tools and technologies that reduce HCPs' exposure to occupational radiation, it seems inevitable that HCPs will bring forth lawsuits at some point.
Adjust workforce counts, risk parameters, and economic valuations to explore different scenarios and understand how changes in assumptions affect the total economic impact.
Launch CalculatorWith the growing evidence regarding the occupational hazards of fluoroscopy, steps need to be taken to safeguard the health of interventional teams who perform life-saving procedures, particularly as demand for complex, minimally invasive treatments is expected to increase. Because of lengthening procedure times, clinicians are assuming greater risk for a host of conditions—brain tumors, premature brain and vascular aging, early development of cataracts, and heightened risk of musculoskeletal injury—in their pursuit of improving the health of others.
As is well known, there are shortcomings with current PPE and radio-protective drapes, most notably orthopedic injury. Immediate attention from all stakeholders is needed to implement interventional lab tools, technologies, and protocols to safeguard HCPs from the adverse health effects of radiation, avoid the nearly $89 million in economic costs in the US, and enable the continued minimally invasive treatment of patients.
This interactive web application updates the December 2018 ORSIF Economic Study, which first quantified the economic costs of occupational health hazards in interventional fluoroscopy. The methodology follows the original study's conservative approach while incorporating the latest available data on workforce demographics, economic valuations, and clinical outcomes.
Data sources include federal agencies (HHS, OSHA, BLS), medical specialty organizations (AAMC, ABIM, SCAI), peer-reviewed literature, and the National Safety Council. Some parameters use placeholder values where primary data was unavailable—these are clearly marked throughout the application.
This economic model is for informational and educational purposes only. It does not constitute medical, legal, or financial advice. The estimates presented are based on available data and modeling assumptions that involve uncertainty.
